The cluster is too small to convey a bearish signal. Monitor for larger insider moves or C-suite participation before drawing conclusions. The company's strong analyst consensus (86% bullish) and recent institutional accumulation suggest no near-term concern.
ARQT drugs
ARQT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 18 $26.21entry
- T+1 · 5mo ago +1.72%α +2.03% · $26.66
- T+5 · 5mo ago +1.83%α +3.50% · $26.69
- T+20 · 4mo ago +5.84%α +5.30% · $27.74
- T+60 · 2mo ago −7.40%α −9.30% · $24.27
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two directors at Arcutis Biotherapeutics sold a combined $221K in open-market transactions over a 7-day window. The total value represents approximately 0.007% of the company's $3.2B market cap, making this a trivial cluster with no material signal for traders.
Key Financial Metrics
Key Facts
- Two directors (Welgus Howard G. and LIN SUE-JEAN) sold shares totaling $221K
- Total sales represent ~0.007% of ARQT's $3.2B market cap
- Welgus also exercised non-cash derivative transactions (822 shares at $0 and 822 shares at $6.52) alongside the sales
- No C-suite executives participated in the cluster
Financial Impact
Insider sales of $221K, negligible relative to $3.2B market cap
Risk Factors
- Insider selling could accelerate if stock price continues to rise, but current levels are routine
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ARQT-1781743656282 |
Track record
34 reports on ARQT
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
- Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
- Nov 4, 202612d ago 8-K Neutral 5/10 No price data
- Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers